
Ertapenem Injectable (Iv/Im) Suppliers & Bulk Manufacturers
Available Forms: Injectable (IV/IM)
Available Strengths: 1 g per vial for IV or IM use
Reference Brands: Invanz(US & EU)
Category: Antibiotics
Ertapenem Injectable (IV/IM) is available in Injectable (IV/IM) and strengths such as 1 g per vial for IV or IM use. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Ertapenem Injectable (IV/IM) is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Technical Specifications & Supply Details | |
---|---|
Lead Time | 7 to 60 days (depending on batch size & schedule) |
MOQ | As per manufacturer’s batch size |
COA | Available with every batch |
Regulatory Dossier / DMF | Available upon request |
Export Documentation | FSC, COA, Manufacturing License, Product Permission |
Standards | IP, BP, USP |
Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Ertapenem Injectable (IV/IM) can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
Ertapenem injectable is approved in the EU and US for treating complicated intra-abdominal infections, skin and soft tissue infections, and community-acquired pneumonia. In the EU, brands like Invanz are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, FDA-approved formulations are based on extensive clinical data; generic versions are available. Both regions require detailed dossiers, including clinical trial results, manufacturing practices, and pharmacovigilance plans, for approval and ongoing safety monitoring. For regulatory support, dossier preparation, and compliance, visit PharmaTradz. We facilitate seamless market access, ensuring adherence to European and US standards for safe, effective antibacterial therapy.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Isoniazid + Rifampicin
Strength:
300mg+150mg, 100mg+150mg
Form: Capsules / Tablet
Reference Brands: Rifamate (USA), IsonaRif (USA), Rifinah(UK)
View DetailsCefazolin
Strength:
500mg, 1g, 2g
Form: Injection
Reference Brands: Kefzol (USA), Cefacidal (EU)
View DetailsAzlocillin Sodium
Strength:
500mg, 1g, 1.5g
Form: Injection
Reference Brands: Generic formulations marketed under different names
View DetailsCefoxitin
Strength:
1 g, 2 g
Form: Injectable powder for solution
Reference Brands: Mefoxin (US/EU/UK), Cefosenz
View DetailsQuick Response Guaranteed | Verified Suppliers